Watchman: New COVID-19 Kill Shot Vaccinations Have Been Approved by the FDA in an Effort to Combat the Decreasing Efficiency of Previous Kill Shot Vaccines, and as a Result, the “Kill Shot” Is Now Considerably More Effective ( Death Almost Immediately) . Heed the Advice From Satan Soldiers at the FDA. Srh: Screw You FDA

HNewsWire:

U.S. drug regulators on Sept. 11 cleared new COVID-19 vaccines to try to counter the poor effectiveness the current slate provide.The U.S. Food and Drug Administration (FDA) cleared shots from Moderna and Pfizer that will be available to Americans as young as 6 months of age later this month.

“Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” Dr. Peter Marks, a top FDA official, said in a statement. “We very much encourage those who are eligible to consider getting vaccinated.”

The FDA approved the Moderna and Pfizer vaccines for people aged 12 and older. Regulators granted emergency authorization for the shots for people aged 6 months to 11 years of age.There was no mention of Novavax, whose vaccine is also available in the United States at present.

The authorizations came despite a dearth of data from clinical trials.Moderna says its new shot in a trial induced immune responses against EG.5 and other newer variants.Pfizer says preclinical data has shown antibodies generated by its new vaccine “effectively neutralize” EG.5, also known as Eris.

The new shots were authorized based on studies on neutralizing antibody levels that appeared to show “a similar magnitude to the extent of neutralization observed with prior versions of the vaccines against corresponding prior variants against which they had been developed to provide protection,” the FDA said. “This suggests that the vaccines are a good match for protecting against the currently circulating COVID-19 variants.”

The CDC plans to meet with its advisers on Tuesday to consider to which populations it should recommend receive the new vaccines. If the panel recommends a vaccine, the federal government must pay for it.

Many countries have suggested younger, healthy people not to receive COVID-19 vaccinations as the disease has died down.

Pfizer and Moderna have said the new shots will cost approximately $110 to $130.

Number of Shots

The new shots are cleared for varying numbers of shots, depending on age group and prior vaccination.People aged 5 years and older, whether or not they’ve received a vaccine, are eligible to receive a single dose of one of the new shots.Children aged 6 months through 4 years who have previously been vaccinated can receive one or two doses of one of the new vaccines.

The FDA said it expects to update the vaccines on an annual basis. That’s currently done for the influenza vaccines.A survey of more than 2,000 adults in Arizona found that the primary reason for not receiving a bivalent was having protection from prior infection.

Other papers have found the vaccines cause cardiac problems like heart inflammation, the doctor noted.”It’s truly irresponsible for FDA, CDC, and others to be championing something … when we don’t know the implications of it,” he said.Dr. Paul Offit, an FDA adviser, suggested to the Daily Mail that younger, healthy people who have already been vaccinated do not need one of the new doses.

“We are best served by targeting these booster doses to those who are most at risk of severe disease,” such as people over 75 years of age, Dr. Offit said. “Boosting otherwise healthy young people is a low-risk, low-reward strategy,” he added.